185 related articles for article (PubMed ID: 38585192)
1. Systematic Review of Intralesional Therapies for Cutaneous Warts.
Mullen SA; Myers EL; Brenner RL; Nguyen KT; Harper TA; Welsh D; Keffer S; Mueller J; Whitley MJ
JID Innov; 2024 May; 4(3):100264. PubMed ID: 38585192
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of the efficacy and safety of intralesional measles, mumps, and rubella vaccine versus intralesional vitamin D3 for the treatment of warts in children.
Mohta A; Kushwaha RK; Gautam U; Sharma P; Nyati A; Jain SK
Pediatr Dermatol; 2020 Sep; 37(5):853-859. PubMed ID: 32681688
[TBL] [Abstract][Full Text] [Related]
3. Intralesional immunotherapy for pediatric warts: A review.
Fields JR; Saikaly SK; Schoch JJ
Pediatr Dermatol; 2020 Mar; 37(2):265-271. PubMed ID: 31930595
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of intralesional tuberculin protein purified derivative (PPD) and intralesional measles, mumps, rubella (MMR) vaccine for multiple resistant warts.
Mohammed YF; Ibrahim HS; Elbarbary MA; Elsaie ML
J Cosmet Dermatol; 2021 Mar; 20(3):868-874. PubMed ID: 33118675
[TBL] [Abstract][Full Text] [Related]
5. A comparative evaluation of therapeutic response in warts to intralesional vitamin D3 versus intralesional measles, mumps, and rubella vaccine.
Singh AK; Devi KN; Bist JS
Dermatol Ther; 2022 Nov; 35(11):e15813. PubMed ID: 36088627
[TBL] [Abstract][Full Text] [Related]
6. A Study of Comparison and Evaluation of Various Intralesional Therapies in Cutaneous Warts.
Chaudhary M; Brar A; Agarwal P; Chavda V; Jagati A; Rathod SP
Indian Dermatol Online J; 2023; 14(4):487-492. PubMed ID: 37521234
[TBL] [Abstract][Full Text] [Related]
7. Intralesional Measles, Mumps, Rubella Vaccine versus Tuberculin Purified Protein Derivative Injections in the Treatment of Palmoplantar and Periungual Warts: A Double-Blind Randomized Controlled Trial.
Rutnin S; Namasondhi A; Pomsoong C; Kositkuljorn C; Anuntrangsee T; Thadanipon K
Dermatology; 2023; 239(1):109-115. PubMed ID: 36282051
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Efficacy of Intralesional Measles, Mumps, and Rubella Vaccine with Intralesional Vitamin D3 as Immunotherapies in the Treatment of Recalcitrant Cutaneous Warts in Adult- A Randomized Placebo-Controlled Study.
Mohta A; Kushwaha RK; Agrawal A; Sharma MK; Gautam U; Jain SK
Indian Dermatol Online J; 2021; 12(6):879-887. PubMed ID: 34934726
[TBL] [Abstract][Full Text] [Related]
9. Intralesional measles-mumps-rubella is associated with a higher complete response in cutaneous warts: a systematic review and meta-analysis of randomized controlled trial including GRADE qualification.
Vania R; Pranata R; Tan ST
J Dermatolog Treat; 2021 Dec; 32(8):1010-1017. PubMed ID: 31985307
[TBL] [Abstract][Full Text] [Related]
10. Comparative Study in Efficacy and Safety of Intralesional Injections of Vitamin D3, Measles Rubella (MR) Vaccine, and Purified Protein Derivative (PPD) in the Management of Cutaneous Warts.
Ahmed R; Bhadbhade SP; Noojibail B; Shetty SM; Varghese A
J Cutan Aesthet Surg; 2020; 13(4):326-332. PubMed ID: 33911414
[TBL] [Abstract][Full Text] [Related]
11. A Comparative Study of Intralesional Vitamin D3, Measles Mumps Rubella Vaccine, and Tuberculin Purified Protein Derivative in the Treatment of Recalcitrant Warts: An Approach to Solve a Therapeutic Conundrum.
Jain S; Marfatia YS
J Clin Aesthet Dermatol; 2021 Nov; 14(11):26-34. PubMed ID: 34980956
[TBL] [Abstract][Full Text] [Related]
12. Triple Intralesional Antigen Immunotherapy versus Monoantigen in the Treatment of Multiple Recalcitrant Warts.
Nofal AA; Elkholy BM; Abd-Elmonsef ER; Nofal HO
Dermatol Ther (Heidelb); 2022 May; 12(5):1225-1237. PubMed ID: 35449500
[TBL] [Abstract][Full Text] [Related]
13. Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: a comparative clinical and immunological study.
Shaheen MA; Salem SA; Fouad DA; El-Fatah AA
Dermatol Ther; 2015; 28(4):194-200. PubMed ID: 25847793
[TBL] [Abstract][Full Text] [Related]
14. Intralesional measles, mumps, and rubella vaccine after failure of intralesional Candida antigen for the treatment of recalcitrant pediatric warts.
Ulschmid CM; Patel J; Pan AY; Liegl M; Holland KE
Pediatr Dermatol; 2023; 40(6):1057-1059. PubMed ID: 37596908
[TBL] [Abstract][Full Text] [Related]
15. Intralesional injection of Candida albicans antigen versus measles, mumps, and rubella vaccine for treatment of plantar warts.
Rageh RM; Hewedy ES; Hegab DS
Acta Dermatovenerol Alp Pannonica Adriat; 2021 Mar; 30(1):1-5. PubMed ID: 33765749
[TBL] [Abstract][Full Text] [Related]
16. Intralesional Measles, Mumps, and Rubella Vaccine Versus Intralesional
Nofal A; El-Arab RE; Nasr M; Alakad R
J Cutan Med Surg; 2021; 25(4):377-383. PubMed ID: 33533654
[TBL] [Abstract][Full Text] [Related]
17. Treatment of recalcitrant warts with intralesional measles, mumps, and rubella vaccine: a promising approach.
Nofal A; Nofal E; Yosef A; Nofal H
Int J Dermatol; 2015 Jun; 54(6):667-71. PubMed ID: 25070525
[TBL] [Abstract][Full Text] [Related]
18. A review of intralesional wart therapy.
Muse ME; Stiff KM; Glines KR; Cline A; Feldman SR
Dermatol Online J; 2020 Mar; 26(3):. PubMed ID: 32609439
[TBL] [Abstract][Full Text] [Related]
19. A Study to Evaluate the Role of Intradermal and Intralesional Measles, Mumps, Rubella (MMR) Vaccine in Treatment of Common Warts.
Gupta P; Tegta GR; Verma GK; Gupta A; Gupta M; Sharma S
Indian Dermatol Online J; 2020; 11(4):559-565. PubMed ID: 32832442
[TBL] [Abstract][Full Text] [Related]
20. Comparative study between intralesional injection of MMR, BCG, and candida albicans antigen in treatment of multiple recalcitrant warts.
Eldahshan RM; Ashry WMO; Elsaie ML
J Cosmet Dermatol; 2022 Mar; 21(3):1120-1126. PubMed ID: 34998000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]